AMRZ Amrize Ltd - Fundamental Analysis
NEUTRAL
Sign in to save
Save this symbol to a watchlist or track a position.
AMRZ Stock | Fundamental Analysis & Investment Insights
NYSE
Basic Materials
Building Materials
Current Price
Live
$54.24
Analyst Target
$60.08
+10.8%
Upside
52W High
$58.11
52W Low
$44.12
At a glance
Key valuation, profitability, growth, and risk metrics.
Updated Jan 24, 2026
Market cap
$30.0B
P/E
22.98
ROE
10.3%
Profit margin
10.0%
Debt/Equity
0.53
Dividend yield
N/A
AI Analysis
Powered by advanced machine learning algorithms
Confidence Score
68%
Analysis Accuracy
The company exhibits a Piotroski F-Score of 4/9, indicating stable but not robust financial health, while the absence of an Altman Z-Score limits distress risk assessment. Valuation metrics suggest the stock trades at a premium to both the Graham Number ($35.19) and intrinsic value ($16.52), supported by a high P/E of 22.98 versus sector peers. Despite solid operating margins and manageable leverage, earnings growth is negative year-over-year and quarterly earnings surprises have been inconsistent. Analysts recommend a 'buy' with a target price of $60.08, implying upside, but weak recent price performance and lack of dividend or insider activity temper near-term conviction.
Key Strengths
Operating margin of 21.33% is strong relative to sector average
Debt/Equity ratio of 0.53 is below peer average of 0.63, indicating conservative leverage
Analyst consensus recommendation is 'buy' with 20 analysts covering
Current ratio of 1.45 suggests adequate short-term liquidity
Revenue growth of 6.60% YoY outpaces some peers like PPG and Dow
Key Risks
Piotroski F-Score of 4/9 indicates borderline financial health with risk of deterioration
Earnings growth is negative YoY (-2.00%) despite revenue growth, signaling margin pressure
Quarterly earnings beat rate is low at 1 out of 3 with an average surprise of -3.57%
Stock trades significantly above Graham Number ($54.24 vs $35.19), suggesting overvaluation on defensive criteria
No Altman Z-Score available, creating a gap in financial distress risk assessment
AI Fair Value Estimate
Based on comprehensive analysis
$38.5
-29.0% below current price
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Overall
47
Moderate
45
58
52
50
30
AI Verdict
Moderately positive with caution due to valuation and earnings inconsistency
Key drivers: Analyst buy rating, Strong operating margin, Premium valuation, Weak earnings growth, Low Piotroski score
Confidence
70%
Value
45/100
Ref P/E, PEG, Graham Number
Positives
- P/E of 22.98 is below sector average of 37.04
Watchpoints
- Price significantly above Graham Number ($54.24 vs $35.19)
- Intrinsic value estimate much lower at $16.52
- PEG ratio unavailable, limiting growth-adjusted valuation
Future
58/100
Ref Growth rates
Positives
- Forward P/E of 19.94 suggests earnings improvement expected
- Most recent Q/Q EPS growth strong at +18.9%
Watchpoints
- Earnings growth YoY is negative (-2.00%)
- Revenue growth of 6.60% is modest
Past
52/100
Ref Historical trends
Positives
- 1-year, 3-year, and 5-year returns are positive (+4.3%)
- 6-month return of +5.7% outperforms 1-year trend
Watchpoints
- 1-month and 1-week returns negative (-2.9%, -0.5%)
- Inconsistent quarterly earnings performance
Health
50/100
Ref Altman Z-Score, Piotroski F-Score
Positives
- Piotroski F-Score of 4/9 indicates stability
- Current ratio of 1.45 and quick ratio of 0.93 show acceptable liquidity
Watchpoints
- Piotroski score below 7 signals financial weaknesses
- Altman Z-Score not available, limiting distress risk analysis
Dividend
30/100
Ref Yield, Payout
Positives
No standout positives identified.
Watchpoints
- Dividend Strength score of 0/100
- No dividend yield or payout history
- Payout ratio is 0.00%
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Current Price
$54.24
Analyst Target
$60.08
Upside/Downside
+10.8%
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for AMRZ and closest competitors.
Updated 2026-01-23
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
AMRZ
Amrize Ltd
Primary
|
+4.3% | +4.3% | +4.3% | +5.7% | -2.9% | -0.5% |
|
PPG
PPG Industries, Inc.
Peer
|
-16.1% | -9.9% | -5.4% | -2.4% | +6.3% | +2.6% |
|
ALB
Albemarle Corporation
Peer
|
+13.7% | -25.1% | +115.4% | +128.2% | +27.6% | +16.2% |
|
DOW
Dow Inc.
Peer
|
-37.1% | -42.6% | -27.5% | +0.1% | +19.5% | +4.7% |
|
AGI
Alamos Gold Inc.
Peer
|
+472.0% | +288.1% | +116.2% | +67.8% | +7.6% | +11.6% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Historical data shows last 12 quarters (3 years)
Valuation Metrics
Key valuation ratios and pricing indicators
P/E Ratio
22.98
Forward P/E
19.94
PEG Ratio
N/A
P/B Ratio
2.33
P/S Ratio
2.54
EV/Revenue
3.05
EV/EBITDA
12.65
Market Cap
$30.0B
Profitability
Profit margins and return metrics
Profit Margin
9.96%
Operating Margin
21.33%
Gross Margin
25.8%
ROE
10.35%
ROA
5.15%
Growth
Revenue and earnings growth rates
Revenue Growth
+6.6%
Earnings Growth
-2.0%
Q/Q Revenue Growth
N/A
Q/Q Earnings Growth
-1.4%
Financial Health
Balance sheet strength and liquidity metrics
Debt/Equity
0.53
Moderate
Current Ratio
1.45
Good
Quick Ratio
0.93
Poor
Cash/Share
$1.49
Quarterly Earnings History
EPS performance vs analyst estimates
2026-02-17
$N/A
2025-10-28
$1.13
+10.2% surprise
2025-08-06
$0.95
-17.4% surprise
Basic Materials Sector Comparison
Comparing AMRZ against 41 companies in the Basic Materials sector
(1 bullish, 21 neutral, 19 bearish)
P/E Ratio
22.98
This Stock
vs
30.38
Sector Avg
-24.4%
(Discount)
Return on Equity (ROE)
10.35%
This Stock
vs
0.39%
Sector Avg
+2521.3%
(Excellent)
Profit Margin
9.96%
This Stock
vs
-2.52%
Sector Avg
-494.8%
(Weaker)
Debt to Equity
0.53
This Stock
vs
0.61
Sector Avg
-11.8%
(Lower)
Revenue Growth
6.6%
This Stock
vs
14.81%
Sector Avg
-55.4%
(Slower)
Current Ratio
1.45
This Stock
vs
2.28
Sector Avg
-36.4%
(Weaker)
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
AMRZ
Amrize Ltd
|
NEUTRAL | $30.0B | 22.98 | 10.3% | 10.0% | $54.24 | |
|
PPG
PPG Industries, Inc.
|
NEUTRAL | $24.88B | 19.72 | 16.2% | 6.3% | $110.22 | |
|
ALB
Albemarle Corporation
|
BEARISH | $22.3B | - | 0.2% | -0.4% | $189.51 | |
|
DOW
Dow Inc.
|
BEARISH | $19.6B | - | -5.3% | -2.8% | $27.57 | |
|
AGI
Alamos Gold Inc.
|
NEUTRAL | $18.23B | 32.89 | 14.3% | 33.5% | $43.42 |
Recent Insider Trading
Insider buy and sell transactions from the last 6 months
| Date | Insider | Position | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2025-11-19 | GANGESTAD NICHOLAS C. | Director | Purchase | 2,000 | $94,680 |
| 2025-11-04 | HILL JAIME | Officer | Purchase | 4,000 | $202,740 |
| 2025-10-31 | BROUWER ROALD | Chief Technology Officer | Purchase | 4,000 | $207,100 |
| 2025-10-30 | JENISCH JAN | Chief Executive Officer | Purchase | 110,000 | $5,803,600 |
| 2025-08-27 | BROUWER ROALD | Chief Technology Officer | Purchase | 2,000 | $103,760 |
| 2025-08-22 | HILL JAIME | Officer | Purchase | 500 | $24,792 |
| 2025-08-15 | CLARK STEPHEN S | Officer | Purchase | 5,000 | $259,122 |
| 2025-08-15 | HILL JAIME | Officer | Purchase | 4,000 | $207,980 |
| 2025-08-13 | GROSS MARIO | Officer | Purchase | 3,000 | $148,890 |
| 2025-08-12 | BROUWER ROALD | Chief Technology Officer | Purchase | 3,000 | $141,168 |
| 2025-08-11 | LADHANI HOLLI C | Director | Stock Award | 2,958 | - |
| 2025-08-11 | GANGESTAD NICHOLAS C. | Director | Stock Award | 2,958 | - |
| 2025-08-11 | GIBSON DWIGHT AUDLEY KONRAD | Director | Stock Award | 2,958 | - |
| 2025-08-11 | DREW THERESA J | Director | Stock Award | 2,958 | - |
| 2025-08-11 | GOSA JAMES JAKE | Officer | Stock Award | 55,639 | - |
Insider transactions can signal confidence or concerns about company prospects
Wall Street Analysts
Professional analyst ratings and price targets
Consensus
BUY
20 analysts
Oppenheimer
2026-01-15
Outperform
Outperform
Citigroup
2026-01-08
Buy
Buy
UBS
2026-01-08
Neutral
Neutral
RBC Capital
2025-12-08
Outperform
Sector Perform
Stephens & Co.
2025-11-14
Overweight
UBS
2025-11-03
Neutral
Neutral
Citigroup
2025-11-03
Buy
Buy
Wells Fargo
2025-10-30
Overweight
Overweight
Citigroup
2025-10-17
Buy
UBS
2025-10-14
Neutral
Neutral
Past News Coverage
Recent headlines mentioning AMRZ from our newsroom.
Newest → oldest
No matching news yet.